Literature DB >> 8759898

Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukaemia.

T Yamagata1, K Mitani, Y Kanda, Y Yazaki, H Hirai.   

Abstract

A variant form of BCR/ABL junction was identified in a patient with chronic myelogenous leukaemia (CML). The BCR/ABL fusion mRNA of this patient showed in-frame junction between BCR exon c3 and ABL exon 2. Although the diagnosis of CML was made, the patient showed clinical features of essential thrombocythaemia (ET) rather than that of typical CML. Treatment with interferon-alpha showed no cytogenetic response. The c3-a2 type of BCR/ABL junction seems to be associated with elevated platelet count and thus could form a novel clinical entity different from typical CML.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8759898     DOI: 10.1046/j.1365-2141.1996.d01-1798.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Chronic myeloid leukaemia with extreme thrombocytosis.

Authors:  Shailendra Prasad Verma; Arunkumar Subbiah; Sajini Elizabeth Jacob; Debdatta Basu
Journal:  BMJ Case Rep       Date:  2015-08-19

2.  Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring.

Authors:  Stephen E Langabeer; Sarah L McCarron; Johanna Kelly; Janusz Krawczyk; Suzanne McPherson; Kanthi Perera; Philip T Murphy
Journal:  Case Rep Hematol       Date:  2012-07-02

Review 3.  Clonal hematopoietic mutations linked to platelet traits and the risk of thrombosis or bleeding.

Authors:  Alicia Veninga; Ilaria De Simone; Johan W M Heemskerk; Hugo Ten Cate; Paola E J van der Meijden
Journal:  Haematologica       Date:  2020-06-18       Impact factor: 9.941

4.  Frequency of BCR-ABL Transcript Types in Syrian CML Patients.

Authors:  Sulaf Farhat-Maghribi; Wafa Habbal; Fawza Monem
Journal:  J Oncol       Date:  2016-05-30       Impact factor: 4.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.